Work

A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations

Year: 2018

Type: article

Study design: Clinical Trial

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2018.10.014

Authors: Hisao Imai, Kyoichi Kaira, Kensuke Suzuki, Masaki Anzai, Takeshi Tsuda, Tamotsu Ishizuka, Tomohito Kuwako, Ichiro Naruse, Kenji Nemoto, Junji Uchino, Nobutoshi Morozumi, Shinichi Ishihara, Koichi Minato, Takeshi Hisada

Institutions: Gunma Prefectural Cancer Center, Gunma University, Toyama Prefectural Central Hospital, University of Fukui, National Hospital Organization Shibukawa Medical Center, Hidaka Hospital, Hidaka Hospital, National Hospital Organization, Ibarakihigashi National Hospital, Kyoto Prefectural University of Medicine, Saku Central Hospital Advanced Care Center, Isesaki Municipal Hospital, Gunma University Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2896115288

FWCI: 4.096

Cites: 36

Cited by: 49

Related to: 10